Prescribing information to support QIPP document
22 February 2012
GPs are set to be enrolled in schemes to switch patients en masse to atorvastatin in the wake of an analysis for the Government's QIPP programme finding its price could plummet by as much as 95% when it comes off patent later this year.
Read the 'Prescribing information to support QIPP' document here
Pulse October survey
Take our July 2025 survey to potentially win £1.000 worth of tokens
